Cargando…
Indications, contraindications and limitations of endoscopic therapy for Barrett’s esophagus and early esophageal adenocarcinoma
Endoscopic eradication therapy (EET) has revolutionized management of Barrett’s esophagus (BE)-associated neoplasia, traditionally treated by esophagectomy, which carries very high mortality and morbidity. EET, usually performed in the outpatient setting, has a safe risk profile. It is indicated in...
Autores principales: | Rouphael, Carol, Anil Kumar, Mythri, Sanaka, Madhusudhan R., Thota, Prashanthi N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257851/ https://www.ncbi.nlm.nih.gov/pubmed/32523628 http://dx.doi.org/10.1177/1756284820924209 |
Ejemplares similares
-
Chemoprevention in Barrett’s esophagus and esophageal
adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021) -
Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here?
por: Singh, Tavankit, et al.
Publicado: (2018) -
Higher risk of neoplastic progression of Barrett’s esophagus in patients with systemic sclerosis
por: Anilkumar, Mythri, et al.
Publicado: (2021) -
Risk of progression of Barrett's esophagus in patients with cirrhosis
por: Apfel, Tehilla, et al.
Publicado: (2017) -
Vitamin D in esophageal cancer: Is there a role for chemoprevention?
por: Rouphael, Carol, et al.
Publicado: (2018)